r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

AV

Adam M. Veness

Insider · SVP, General Counsel and Sec. · DNTH

Adam M. Veness files insider transactions with the SEC as a svp, general counsel and sec. of Dianthus Therapeutics, Inc. /DE/ (DNTH). We hold 3 disclosed purchases and sales filed since 7 June 2019, 3 of them in the last 90 days.

  • Files forDNTH
  • Disclosed buys and sells3 in all, 3 in the last 90 days
  • Last disclosure14 August 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 24 January 2024 — 13 August 2026SVP, General Counsel and Sec. · Dianthus Therapeutics, Inc. /DE/ (DNTH)18 Form 4 lines · source: SEC Form 4
  • Filed 2 May 2022 — 3 February 2023General Counsel · Cyteir Therapeutics (CYT)2 Form 4 lines · source: SEC Form 4
  • Filed 5 June 2019 — 19 November 2021SVP, General Counsel and Sec. · Acceleron Pharma (XLRN)42 Form 4 lines · source: SEC Form 4

Everything they disclosed

62 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.